ENTITY
Hansoh Pharmaceutical Group

Hansoh Pharmaceutical Group (3692 HK)

171
Analysis
Health CareChina
Hansoh Pharmaceutical Group Company Limited operates as a pharmaceutical company. The Company manufactures and sells anti-infectives, anti-neoplastic agents, diabetes drugs, and other products. Hansoh Pharmaceutical Group markets its products throughout China.
more
Refresh
18 May 2020 18:26

HSCEI Consultation on WVRs & Secondary Listings - All Proposals Get the Green Light

On 13 January, Hang Seng Indexes Limited (HSIL) had released a consultation paper on proposed changes to the Hang Seng Index (HSI) and the Hang...

Logo
238 Views
Share
13 May 2020 07:56

China Health Care - Allocation Boom: Wuxi Biologics/Jinyu Bio-Tech/Hangzhou Tigermed Top Picks

With increased focus on the Health Care sector in light of the COVID-19 pandemic, Health Care allocations reached record levels last month. We...

Logo
301 Views
Share
11 May 2020 14:25

Short Interest Spiked for China Gas, Country Garden Svc, Big Covers for Innovent

Hong Kong SFC reported today for aggregate short position on Apr 29. The aggregate short value for equities increased by $1,489m (+2.7%) WoW and...

Logo
225 Views
Share
bullishKingsoft Cloud
26 Apr 2020 12:44

ECM Weekly (26 Apr 2020) - Kingsoft Cloud, WeDoctor, Akesobio, Kotak Mahindra Bank

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Akeso...

Share
21 Apr 2020 21:49

Hansoh Pharma Placement - Good Stock but Valuation and No Lack of Cash Makes It Appear Opportunistic

Hansoh Pharmaceutical (3692 HK) aims to raise up to US$450m to funds its R&D and general working capital requirements. The company was listed...

Logo
388 Views
Share
x